CSF2 and COVID-19: While the response of basophils, monocytes, and neutrophils to T-cell activation with anti-CD3 was very low in COVID-19 patients, their response to recombinant IL-3 and GM-CSF was fully preserved in a cell-type-specific manner (preferential response of basophils to IL-3, of monocytes to IL-3 and GM-CSF, and of neutrophils to GM-CSF).